ÂÜÀòÂÒÂ×

Mr. Burns is CEO of Bruin Biometrics, an innovative medical device company developing systems that can cost-effectively detect and monitor select medical conditions. Appointed CEO in 2012, Martin established and led the successful journey of BBI’s SEM Scanner through FDA de novo Marketing Authorization (2018), CE Marking (2013) and the UK's National Institute of Health and Care Excellence' (NICE) Medical Innovation Briefing process (MIB 182, 2019). Previously, he spent more than 15 years as a management consultant at Deloitte and PricewaterhouseCoopers. Mr. Burns has led corporate strategy, innovation, operations, quality and regulatory, M&A and global expansion assignments for medical device and life sciences companies. Martin earned his BA (1996) at the London School of Economics and Political Science (LSE) and his MBA at UCLA’s Anderson School of Management (2007).